| Date | Name | Shares | Transaction | Value |
|
Nov 18, 2025
| Richard A. Dierker President and CEO; Director |
15,739
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Nov 18, 2025
| Carlos G. Linares EVP Chief Tech&Global New Prod |
17,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Nov 18, 2025
| Brian Buchert EVP of Strategy, M&A, and BP |
605
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jun 17, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
2,427
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
4,442
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $73.87 per share |
328,130.54
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
262
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $98.75 per share |
25,872.50
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
262
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $98.75 per share |
25,872.50
|
|
Jun 3, 2025
| Ravichandra K. Saligram Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jun 3, 2025
| Ravichandra K. Saligram Director |
13,747
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99 per share |
1,360,953.00
|
|
Jun 3, 2025
| Ravichandra K. Saligram Director |
28,407
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $41.92 per share |
1,190,821.44
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
262
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $98.75 per share |
25,872.50
|
|
Jun 3, 2025
| Carlen Hooker EVP, Chief Commercial Officer |
5,742
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $84.54 per share |
485,428.68
|
|
Apr 17, 2025
| Matthew Thomas Farrell President and CEO; Director |
110,050
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 9, 2025
| Matthew Thomas Farrell President and CEO; Director |
4,548
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $109.47 per share |
497,869.56
|
|
Apr 9, 2025
| Matthew Thomas Farrell President and CEO; Director |
1,018
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $109.47 per share |
111,440.46
|
|
Mar 26, 2025
| Lee Brett Mcchesney EVP, Chief Financial Officer |
16,530
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 26, 2025
| Lee Brett Mcchesney EVP, Chief Financial Officer |
20,580
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $106.9 per share |
2,200,002.00
|